NSAIDs and breast cancer recurrence in a prospective cohort study

Cancer Causes and Control

Volumn 18, Issue 6, 2007, Pages 613-620

  Kwan, Marilyn L ^a   Habel, Laurel A ^a   Slattery, Martha L ^b   Caan, Bette ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Anti inflammatory agents; Breast neoplasms; Chemoprevention; Non steroidal; Recurrence

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NAPROXEN; SULINDAC; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVOR; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CALIFORNIA; CHEMOPREVENTION; COHORT STUDIES; FEMALE; HUMANS; IBUPROFEN; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK; SURVIVORS;

EID: 34250022123     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-007-9003-y     Document Type: Article

References (24)

1. http://http://www.cancer/. (2006) org, American Cancer Society
2. Harris RE, Chlebowski RT, Jackson RD, et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 63(18):6096-6101
3. Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84(9):1188-1192
4. Moorman PG, Grubber JM, Millikan RC, Newman B (2003) Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 14(10):915-922
5. Swede H, Mirand AL, Menezes RJ, Moysich KB (2005) Association of regular aspirin use and breast cancer risk. Oncology 68(1): 40-47
6. Terry MB, Gammon MD, Zhang FF, et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. Jama 291(20):2433-2440
7. Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L (2005) Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 162(2):165-170
8. Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3:28
9. Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. Jama 294(1):47-55
10. Jacobs EJ, Thun MJ, Connell CJ et al (2005) Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 14(1):261-264
11. Marshall SF, Bernstein L, Anton-Culver H et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97(11):805-812
12. Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML (2005) Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16(5):545-556
13. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. Jama 293(20):2479-2486
14. Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. John Wiley & Sons, Inc, New York
15. Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6(2):130-140
16. Meric JB, Rottey S, Olaussen K et al (2006) Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol 59(1):51-64
17. Alshafie GA, Harris RE, Robertson FM Parrett ML Ross M Abou-Issa H (1999) Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas. Anticancer Res 19(4B):3031-3036
18. Robertson FM, Parrett ML, Joarder FS, et al (1998) Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett 122(1-2):165-175
19. Arun B, Hortobagyi GN (2002) Progress in breast cancer chemoprevention. Endocr Relat Cancer 9(1):15-32
20. Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90(6):455-460
21. Parrett M, Harris R, Joarder F, Ross M, Clausen K, Robertson F (1997) Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 10:503-508
22. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC (2002) Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55(6):429-434
23. Ristimaki A, Sivula A, Lundin J, et al (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62(3):632-635
24. Blair CK, Sweeney C, Anderson KE, Folsom AR (2006) NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat